1887

Chapter 5 : Quantitative Molecular Methods

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Quantitative Molecular Methods, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555816834/9781555814977_Chap05-1.gif /docserver/preview/fulltext/10.1128/9781555816834/9781555814977_Chap05-2.gif

Abstract:

Quantitative molecular methods provide information about the concentration of microbial nucleic acid target present in a sample. The evolution of various quantitative methods includes PCR and commercial alternatives to PCR. Quantitative methods that rely on target amplification include transcription-mediated amplification (TMA) and nucleic acid sequenced-based amplification (NASBA). Commercially available quantitative signal and probe amplification methods include the branched DNA (bDNA) method and the Invader assay, respectively. Quantitative methods based on PCR include three broad categories: quantitative PCR (Q-PCR) is typically used to determine the microbial density or ‘‘load’’ of DNA in clinical specimens; (ii) quantitative reverse transcriptase PCR (QRT-PCR) is used to determine the density of RNA viruses, an approach commonly called ‘‘viral load’’ testing; and (iii) in what are often referred to as ‘‘gene expression’’ assays, QRT-PCR can be used to determine relative mRNA expression levels for different disease states. This chapter concentrates on the technological features unique to quantitative molecular assays. The advantages and limitations of these methods are reviewed in the chapter. For microbial quantitation, whole-organism comparisons are best but not always feasible; therefore, plasmids or oligonucleotides are often used as substitutes. The chapter talks about general issues for viral load measurement, and other general considerations and tips for quantitative methods. Speed, accuracy, and utilization of results will be paramount to the future of quantitative technology as new methods extend our understanding of pathogenesis and advance our ability to improve diagnosis and disease management.

Citation: Wolk D, Hayden R. 2011. Quantitative Molecular Methods, p 83-105. In Persing D, Tenover F, Tang Y, Nolte F, Hayden R, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555816834.ch5

Key Concept Ranking

Reverse Transcriptase PCR
0.73853153
Real-Time PCR
0.591135
Quantitative PCR
0.51200426
Analytical Methods
0.50801754
0.73853153
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Plot of the relative amount of DNA product as a function of amplification efficiency in a 25-cycle PCR assay. The relative final quantity at each amplification efficiency is a percentage of the final amount of PCR product amplified at maximal efficiency (1.0). The inset shows expansion of the 0.7-to-0.9 range.

Citation: Wolk D, Hayden R. 2011. Quantitative Molecular Methods, p 83-105. In Persing D, Tenover F, Tang Y, Nolte F, Hayden R, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555816834.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

(A) Fluorescence output from real-time PCR showing eight samples with corresponding copy numbers and corresponding standard curves derived from the values. Reactions occurring after cycle 45 could depict the formation and amplification of primer-dimers, so sequence analysis of these types of reaction may be necessary. (B) Example of a standard curve derived from real-time Q-PCR with calculations for PCR efficiency. The log of the starting copy number of nucleic acid is plotted against . Samples of unknown concentration can be assessed in comparison to the standard curve. Efficiency can be calculated from the slope of the regression line.

Citation: Wolk D, Hayden R. 2011. Quantitative Molecular Methods, p 83-105. In Persing D, Tenover F, Tang Y, Nolte F, Hayden R, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555816834.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3
FIGURE 3

Diagram of internal control sequences for PCR-based assays. (A) Native template showing the internal probe binding site in the normal orientation. (B and C) Control sequences identical to sequence A but with either deletion of an internal sequence (B) or insertion of an exogenous sequence (C). (D) Control sequence, the same size as the native sequence, containing a substituted sequence. (E) Control sequence with an internal probe-binding sequence in reverse orientation.

Citation: Wolk D, Hayden R. 2011. Quantitative Molecular Methods, p 83-105. In Persing D, Tenover F, Tang Y, Nolte F, Hayden R, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555816834.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555816834.ch05
1. Abe, A.,, K. Inoue,, T. Tanaka,, J. Kato,, N. Kajiyama,, R. Kawaguchi,, S. Tanaka,, M. Yoshiba, and, M. Kohara. 1999. Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J. Clin. Microbiol. 37:28992903.
2. Aberham, C.,, C. Pendl,, P. Gross,, G. Zerlauth, and, M. Gessner. 2001. A quantitative, internally controlled realtime PCR assay for the detection of parvovirus B19 DNA. J. Virol. Methods 92:183191.
3. Abu Al-Soud, W.,, and P. Radstrom. 2000. Effects of amplification facilitators on diagnostic PCR in the presence of blood, feces, and meat. J. Clin. Microbiol. 38:44634470.
4. Akane, A.,, K. Matsubara,, H. Nakamura,, S. Takahashi, and, K. Kimura. 1994. Identification of the heme compound copurified with deoxyribonucleic acid (DNA) from bloodstains, a major inhibitor of polymerase chain reaction (PCR) amplification. J. Forensic Sci. 39:362372.
5. Aliyu, S. H.,, M. H. Aliyu,, H. M. Salihu,, S. Parmar,, H. Jalal, and, M. D. Curran. 2004. Rapid detection and quantitation of hepatitis B virus DNA by real-time PCR using a new fluorescent (FRET) detection system. J. Clin. Virol. 30:191195.
6. Al-Soud, W. A.,, L. J. Jonsson, and, P. Radstrom. 2000. Identification and characterization of immunoglobulin G in blood as a major inhibitor of diagnostic PCR. J. Clin. Microbiol. 38:345350.
7. Amorim, M. L.,, J. M. Cabeda,, R. Seca,, A. C. Mendes,, A. P. Castro, and, J. M. Amorim. 2001. CMV infection of liver transplant recipients: comparison of antigenemia and molecular biology assays. BMC Infect. Dis. 1:2.
8. Ampofo, W. K.,, Y. Koyanagi,, J. Brandful,, K. Ishikawa, and, N. Yamamoto. 1999. Seroreactivity clarification and viral load quantitation in HIV-1 and HIV-2 infections in Ghana. J. Med. Dent. Sci. 46:5362.
9. Ando, Y.,, K. Terao,, M. Narita,, Y. Oguchi,, T. Sata, and, T. Iwasaki. 2002. Quantitative analyses of cytomegalovirus genome in aqueous humor of patients with cytomegalovirus retinitis. Jpn. J. Ophthalmol. 46:254260.
10. Babcock, G. J.,, E. M. Miyashita-Lin, and, D. A. Thorley-Lawson. 2001. Detection of EBV infection at the single-cell level. Precise quantitation of virus-infected cells in vivo. Methods Mol. Biol. 174:103110.
11. Bai, X.,, B. B. Rogers,, P. C. Harkins,, J. Sommerauer,, R. Squires,, K. Rotondo,, A. Quan,, D. B. Dawson, and, R. H. Scheuermann. 2000. Predictive value of quantitative PCR-based viral burden analysis for eight human herpesviruses in pediatric solid organ transplant patients. J. Mol. Diagn. 2:191201.
12. Baldanti, F.,, P. Grossi,, M. Furione,, L. Simoncini,, A. Sarasini,, P. Comoli,, R. Maccario,, R. Fiocchi, and, G. Gerna. 2000. High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders. J. Clin. Microbiol. 38:613619.
13. Ballout, M.,, R. Germi,, S. Fafi-Kremer,, J. Guimet,, G. Bargues,, J. M. Seigneurin, and, P. Morand. 2007. Realtime quantitative PCR for assessment of antiviral drug effects against Epstein-Barr virus replication and EBV late mRNA expression. J. Virol. Methods 143:3844.
14. Bartels, C.,, M. Maass,, G. Bein,, N. Brill,, J. F. Bechtel,, R. Leyh, and, H. H. Sievers. 2000. Association of serology with the endovascular presence of Chlamydia pneumoniae and cytomegalovirus in coronary artery and vein graft disease. Circulation 101:137141.
15. Becker, M. J.,, S. de Marie,, D. Willemse,, H. A. Verbrugh, and, I. A. Bakker-Woudenberg. 2000. Quantitative galactomannan detection is superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an experimental rat model. J. Clin. Microbiol. 38:14341438.
16. Beld, M.,, R. Sentjens,, S. Rebers,, C. Weegink,, J. Weel,, C. Sol, and, R. Boom. 2002. Performance of the New Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: conversion to international units and comparison with the Roche COBAS Amplicor HCV Monitor, Version 2.0, assay. J. Clin. Microbiol. 40:788793.
17. Berger, A.,, H. F. Rabenau,, A. Stief,, H. Troonen, and, H. W. Doerr. 2001. Evaluation of the new LCx HIV RNA quantitative assay: comparison with the Cobas Amplicor HIV Monitor assay. Med. Microbiol. Immunol. (Berlin) 190:129134.
18. Bezold, G.,, P. Gottlober,, U. Leiter,, M. Kerscher,, G. Krahn, and, R. U. Peter. 2000. Quantitation of herpes simplex DNA in blood during aciclovir therapy with competitive PCR ELISA. Dermatology 201:296299.
19. Biel, S. S.,, T. K. Held,, O. Landt,, M. Niedrig,, H. R. Gelderblom,, W. Siegert, and, A. Nitsche. 2000. Rapid quantification and differentiation of human polyomavirus DNA in undiluted urine from patients after bone marrow transplantation. J. Clin. Microbiol. 38:36893695.
20. Boivin, G.,, R. Belanger,, R. Delage,, C. Beliveau,, C. Demers,, N. Goyette, and, J. Roy. 2000. Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the COBAS AMPLICOR CMV MONITOR PCR test after blood and marrow allogeneic transplantation. J. Clin. Microbiol. 38:43564360.
21. Borgmann, S.,, C. Wolz,, S. Grobner,, I. B. Autenrieth,, P. Heeg,, C. Goerke,, K. Muller,, P. Kyme, and, M. Marschal. 2004. Metallo-beta-lactamase expressing multiresistant Acinetobacter baumannii transmitted in the operation area. J. Hosp. Infect. 57:308315.
22. Boriskin, Y. S.,, K. Fuller,, R. L. Powles,, I. B. Vipond,, P. S. Rice,, J. C. Booth,, E. O. Caul, and, P. D. Butcher. 2002. Early detection of cytomegalovirus (CMV) infection in bone marrow transplant patients by reverse transcription-PCR for CMV spliced late gene UL21.5: a two site evaluation. J. Clin. Virol. 24:1323.
23. Boutolleau, D.,, C. Fernandez,, E. Andre,, B. M. Imbert-Marcille,, N. Milpied,, H. Agut, and, A. Gautheret-Dejean. 2003. Human herpesvirus (HHV)-6 and HHV-7: two closely related viruses with different infection profiles in stem cell transplantation recipients. J. Infect. Dis. 187:179186.
24. Bowman, J. C.,, G. K. Abruzzo,, J. W. Anderson,, A. M. Flattery,, C. J. Gill,, V. B. Pikounis,, D. M. Schmatz,, P. A. Liberator, and, C. M. Douglas. 2001. Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate. Antimicrob. Agents Chemother. 45:34743481.
25. Broccolo, F.,, G. Locatelli,, L. Sarmati,, S. Piergiovanni,, F. Veglia,, M. Andreoni,, S. Butto,, B. Ensoli,, P. Lusso, and, M. S. Malnati. 2002. Calibrated real-time PCR assay for quantitation of human herpesvirus 8 DNA in biological fluids. J. Clin. Microbiol. 40:46524658.
26. Bueno, J.,, C. Ramil, and, M. Green. 2002. Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients. Paediatr. Drugs 4:279290.
27. Bukh, J.,, R. H. Purcell, and, R. H. Miller. 1992. Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc. Natl. Acad. Sci. USA 89:187191.
28. Burgisser, P.,, P. Vernazza,, M. Flepp,, J. Boni,, Z. Tomasik,, U. Hummel,, G. Pantaleo, and, J. Schupbach. 2000. Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study. J. Acquir. Immune Defic. Syndr. 23:138144.
29. Busch, M. P.,, J. C. Wilber,, P. Johnson,, L. Tobler, and, C. S. Evans. 1992. Impact of specimen handling and storage on detection of hepatitis C virus RNA. Transfusion 32:420425.
30. Bustin, S. A.,, and R. Mueller. 2005. Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis. Clin. Sci. (London) 109:365379.
31. Cai, T.,, G. Lou,, J. Yang,, D. Xu, and, Z. Meng. 2008. Development and evaluation of real-time loop-mediated isothermal amplification for hepatitis B virus DNA quantification: a new tool for HBV management. J. Clin. Virol. 41:270276.
32. Caliendo, A. M.,, K. St George,, S. Y. Kao,, J. Allega,, B. H. Tan,, R. LaFontaine,, L. Bui, and, C. R. Rinaldo. 2000. Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients. J. Clin. Microbiol. 38:21222127.
33. Candotti, D.,, J. Temple,, S. Owusu-Ofori, and, J. P. Allain. 2004. Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1. J. Virol. Methods 118:3947.
34. Cartwright, C. P. 1999. Synthetic viral particles promise to be valuable in the standardization of molecular diagnostic assays for hepatitis C virus. Clin. Chem. 45:20572059.
35. Castelain, S.,, V. Descamps,, V. Thibault,, C. Francois,, D. Bonte,, V. Morel,, J. Izopet,, D. Capron,, P. Zawadzki, and, G. Duverlie. 2004. TaqMan amplification system with an internal positive control for HCV RNA quantitation. J. Clin. Virol. 31:227234.
36. Centers for Disease Control and Prevention. 2001. Guidelines for laboratory test result reporting of human immunodeficiency virus type 1 ribonucleic acid determination. Recommendations from a CDC working group. MMWR Recommend. Rep. 50:112.
37. Centers for Disease Control and Prevention. 2001. Revised guidelines for HIV counseling, testing, and referral. MMWR Recommend. Rep. 50:157.
38. Centers for Disease Control and Prevention. 2001. Revised recommendations for HIV screening of pregnant women. MMWR Recommend. Rep. 50:6385.
39. Centers for Disease Control and Prevention. 2001. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recommend. Rep. 50:152.
40. Chen, M. Y.,, L. D. Sun,, J. Zhao, and, K. Zeng. 2009. Multiplex fluorescent quantitative PCR for detecting deep fungal infection in patients with systemic lupus erythematosus. Nan Fang Yi Ke Da Xue Xue Bao 29:21122114, 2121. (In Chinese.)
41. Chen, R. W.,, H. Piiparinen,, M. Seppanen,, P. Koskela,, S. Sarna, and, M. Lappalainen. 2001. Real-time PCR for detection and quantitation of hepatitis B virus DNA. J. Med. Virol. 65:250256.
42. Chen, X.,, B. Zehnbauer,, A. Gnirke, and, P. Y. Kwok. 1997. Fluorescence energy transfer detection as a homogeneous DNA diagnostic method. Proc. Natl. Acad. Sci. USA 94:1075610761.
43. Chen, Y.,, F. C. Tenover, and, T. M. Koehler. 2004. Beta-lactamase gene expression in a penicillin-resistant Bacillus anthracis strain. Antimicrob. Agents Chemother. 48:48734877.
44. Chetverina, H. V.,, T. R. Samatov,, V. I. Ugarov, and, A. B. Chetverin. 2002. Molecular colony diagnostics: detection and quantitation of viral nucleic acids by in-gel PCR. BioTechniques 33:150152, 154, 156.
45. Chevret, L.,, D. Boutolleau,, N. Halimi-Idri,, S. Branchereau,, C. Baujard,, M. Fabre,, A. Gautheret-Dejean, and, D. Debray. 2008. Human herpesvirus-6 infection: a prospective study evaluating HHV-6 DNA levels in liver from children with acute liver failure. J. Med. Virol. 80:10511057.
46. Christopherson, C.,, Y. Kidane,, B. Conway,, J. Krowka,, H. Sheppard, and, S. Kwok. 2000. PCR-based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells. J. Clin. Microbiol. 38:630634.
47. Chun, Y. K.,, J. Y. Kim,, H. J. Woo,, S. M. Oh,, I. Kang,, J. Ha, and, S. S. Kim. 2000. No significant correlation exists between core promoter mutations, viral replication, and liver damage in chronic hepatitis B infection. Hepatology 32:11541162.
48. Ciuffreda, D.,, B. Capiluppi,, E. Mastrorilli,, G. Balconi,, G. Tambussi,, A. Lazzarin, and, F. Lillo. 2000. Primary HIV infection: molecular approaches in diagnosis and monitoring. J. Biol. Regul. Homeost. Agents 14:6367.
49. Claas, E. C.,, M. W. Schilham,, C. S. de Brouwer,, P. Hubacek,, M. Echavarria,, A. C. Lankester,, M. J. van Tol, and, A. C. Kroes. 2005. Internally controlled realtime PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients. J. Clin. Microbiol. 43:17381744.
50. Clarke, J. R.,, S. Galpin,, R. Braganza,, A. Ashraf,, R. Russell,, D. R. Churchill,, J. N. Weber, and, M. O. McClure. 2000. Comparative quantification of diverse serotypes of HIV-1 in plasma from a diverse population of patients. J. Med. Virol. 62:445449.
51. Clemons, K. V.,, and D. A. Stevens. 2009. Conventional or molecular measurement of Aspergillus load. Med. Mycol. 47(Suppl. 1):S132S137.
52. CLSI. 2006. Preliminary Evaluation of Quantitative Clinical Laboratory Methods, CLSI Document EP10-A3. Approved Guideline. Clinical Laboratory Standards Institute, Wayne, PA.
53. CLSI. 2006. Statistical Quality Control for Quantitative Measurements: Principles and Definitions, 2nd ed. CLSI Document C24-A3. Approved Guideline. Clinical Laboratory Standards Institute, Wayne, PA.
54. Cohrs, R. J.,, J. Randall,, J. Smith,, D. H. Gilden,, C. Dabrowski,, K. H. van Der, and, R. Tal-Singer. 2000. Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J. Virol. 74:1146411471.
55. Cook, L.,, K. W. Ng,, A. Bagabag,, L. Corey, and, K. R. Jerome. 2004. Use of the MagNA pure LC automated nucleic acid extraction system followed by real-time reverse transcription-PCR for ultrasensitive quantitation of hepatitis C virus RNA. J. Clin. Microbiol. 42:41304136.
56. Corcoran, C.,, K. Rebe,, H. van der Plas,, L. Myer, and, D. R. Hardie. 2008. The predictive value of cerebrospinal fluid Epstein-Barr viral load as a marker of primary central nervous system lymphoma in HIV-infected persons. J. Clin. Virol. 42:433436.
57. Costa, C.,, M. Bergallo,, F. Sidoti,, S. Astegiano,, M. E. Terlizzi,, G. Mazzucco,, G. P. Segoloni, and, R. Cavallo. 2009. Polyomaviruses BK- and JC-DNA quantitation in kidney allograft biopsies. J. Clin. Virol. 44:2023.
58. Cuenca-Estrella, M.,, Y. Meije,, C. Diaz-Pedroche,, A. Gomez-Lopez,, M. J. Buitrago,, L. Bernal-Martinez,, C. Grande,, R. S. Juan,, M. Lizasoain,, J. L. Rodriguez-Tudela, and, J. M. Aguado. 2009. Value of serial quantification of fungal DNA by a real-time PCR-based technique for early diagnosis of invasive aspergillosis in patients with febrile neutropenia. J. Clin. Microbiol. 47:379384.
59. [Reference deleted.]
60. Damond, F.,, M. Gueudin,, S. Pueyo,, I. Farfara,, D. L. Robertson,, D. Descamps,, G. Chene,, S. Matheron,, P. Campa,, F. Brun-Vezinet, and, F. Simon. 2002. Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections. J. Clin. Microbiol. 40:36543659.
61. Davis, G. L.,, J. Y. Lau,, M. S. Urdea,, P. D. Neuwald,, J. C. Wilber,, K. Lindsay,, R. P. Perrillo, and, J. Albrecht. 1994. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 19:13371341.
62. de Baar, M. P.,, E. C. Timmermans,, M. Bakker,, E. de Rooij,, B. van Gemen, and, J. Goudsmit. 2001. One-tube real-time isothermal amplification assay to identify and distinguish human immunodeficiency virus type 1 subtypes A, B, and C and circulating recombinant forms AE and AG. J. Clin. Microbiol. 39:18951902.
63. Defoort, J. P.,, M. Martin,, B. Casano,, S. Prato,, C. Camilla, and, V. Fert. 2000. Simultaneous detection of multiplex-amplified human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA using a flow cytometer microsphere-based hybridization assay. J. Clin. Microbiol. 38:10661071.
64. de Mendoza, C.,, W. Lu,, A. Machuca,, M. Sainz,, J. Castilla, and, V. Soriano. 2001. Monitoring the response to antiretroviral therapy in HIV-1 group O infected patients using two new RT-PCR assays. J. Med. Virol. 64:217222.
65. de Pagter, P. J.,, R. Schuurman,, H. Visscher,, M. de Vos,, M. Bierings,, A. M. van Loon,, C. S. Uiterwaal,, D. van Baarle,, E. A. Sanders, and, J. Boelens. 2008. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome. Biol. Blood Marrow Transplant. 14:831839.
66. Detmer, J.,, R. Lagier,, J. Flynn,, C. Zayati,, J. Kolberg,, M. Collins,, M. Urdea, and, R. Sanchez-Pescador. 1996. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J. Clin. Microbiol. 34:901907.
67. Di, N. A.,, E. Ghezzi,, F. Gillio,, F. Zerilli,, E. Shehi,, D. Maritano,, M. Panizzo,, F. Bonelli, and, D. Adlerstein. 2008. Anchor-based fluorescent amplicon generation assays (FLAG) for real-time measurement of human cytomegalovirus, Epstein-Barr virus, and varicella-zoster virus viral loads. Clin. Chem. 54:19001907.
68. Diamond, C.,, C. Speck,, M. L. Huang,, L. Corey,, R. W. Coombs, and, J. N. Krieger. 2000. Comparison of assays to detect cytomegalovirus shedding in the semen of HIV-infected men. J. Virol. Methods 90:185191.
69. Dockrell, D. H. 2003. Human herpesvirus 6: molecular biology and clinical features. J. Med. Microbiol. 52:518.
70. Dockrell, D. H.,, and C. V. Paya. 2001. Human herpesvirus-6 and -7 in transplantation. Rev. Med. Virol. 11:2336.
71. Dohner, D. E.,, M. S. Dehner, and, L. D. Gelb. 1995. Inhibition of PCR by mineral oil exposed to UV irradiation for prolonged periods. BioTechniques 18:964967.
72. Drew, W. L. 2007. Laboratory diagnosis of cytomegalovirus infection and disease in immunocompromised patients. Curr. Opin. Infect. Dis. 20:408411.
73. Dubois, R. W. 2003. Standards for PCR assays, p. 197-210. In M. A. Innis,, D. H. Gelfand, and, J. Sninsky (ed.), PCR Applications—Protocols for Functional Genomics. Academic Press, New York, NY.
74. Duclos-Vallee, J. C.,, B. Roche, and, D. Samuel. 2009. Liver transplantation in patients with hepatitis B virus, hepatitis C virus, or human immunodeficiency virus. Presse Med. 38:12811289. (In French.)
75. Dufour, D. R.,, J. A. Lott,, F. S. Nolte,, D. R. Gretch,, R. S. Koff, and, L. B. Seeff. 2000. Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clin. Chem. 46:20272049.
76. Dumonceaux, T. J.,, C. Mesa, and, A. Severini. 2008. Internally controlled triplex quantitative PCR assay for human polyomaviruses JC and BK. J. Clin. Microbiol. 46:28292836.
77. Dundas, N.,, N. K. Leos,, M. Mitui,, P. Revell, and, B. B. Rogers. 2008. Comparison of automated nucleic acid extraction methods with manual extraction. J. Mol. Diagn. 10:311316.
78. Dworkin, L. L.,, T. M. Gibler, and, R. N. Van Gelder. 2002. Real-time quantitative polymerase chain reaction diagnosis of infectious posterior uveitis. Arch. Ophthalmol. 120:15341539.
79. Ebner, K.,, M. Rauch,, S. Preuner, and, T. Lion. 2006. Typing of human adenoviruses in specimens from immunosuppressed patients by PCR-fragment length analysis and real-time quantitative PCR. J. Clin. Microbiol. 44:28082815.
80. Ebner, K.,, M. Suda,, F. Watzinger, and, T. Lion. 2005. Molecular detection and quantitative analysis of the entire spectrum of human adenoviruses by a two-reaction real-time PCR assay. J. Clin. Microbiol. 43:30493053.
81. Elfaitouri, A.,, A. L. Hammarin, and, J. Blomberg. 2006. Quantitative real-time PCR assay for detection of human polyomavirus infection. J. Virol. Methods 135:207213.
82. Emery, V. C.,, A. V. Cope,, C. A. Sabin,, A. K. Burroughs,, K. Rolles,, T. Lazzarotto,, M. P. Landini,, S. Brojanac,, J. Wise, and, G. T. Maine. 2000. Relationship between IgM antibody to human cytomegalovirus, virus load, donor and recipient serostatus, and administration of methylprednisolone as risk factors for cytomegalovirus disease after liver transplantation. J. Infect. Dis. 182:16101615.
83. Emery, V. C.,, C. A. Sabin,, A. V. Cope,, D. Gor,, A. F. Hassan-Walker, and, P. D. Griffiths. 2000. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 355:20322036.
84. Engelmann, I.,, D. R. Petzold,, A. Kosinska,, B. G. Hepkema,, T. F. Schulz, and, A. Heim. 2008. Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpesvirus 6 DNA in blood and other clinical specimens. J. Med. Virol. 80:467477.
85. Enomoto, M.,, S. Nishiguchi,, S. Shiomi,, M. Tanaka,, K. Fukuda,, T. Ueda,, A. Tamori,, D. Habu,, T. Takeda,, Y. Yano, and, S. Otani. 2001. Comparison of real-time quantitative polymerase chain reaction with three other assays for quantitation of hepatitis C virus. J. Gastroenterol. Hepatol. 16:904909.
86. Fabrizi, F.,, G. Lunghi,, F. Aucella,, S. Mangano,, F. Barbisoni,, S. Bisegna,, D. Vigilante,, A. Limido, and, P. Martin. 2005. Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients. J. Clin. Microbiol. 43:414420.
87. Fafi-Kremer, S.,, K. Brengel-Pesce,, G. Bargues,, M. J. Bourgeat,, O. Genoulaz,, J. M. Seigneurin, and, P. Morand. 2004. Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma. J. Clin. Virol. 30:157164.
88. Fafi-Kremer, S.,, P. Morand,, C. Barranger,, G. Bargues,, S. Magro,, J. Bes,, P. Bourgeois,, M. Joannes, and, J. M. Seigneurin. 2008. Evaluation of the Epstein-Barr virus R-gene quantification kit in whole blood with different extraction methods and PCR platforms. J. Mol. Diagn. 10:7884.
89. Fan, H.,, S. A. Schichman,, L. J. Swinnen,, J. M. Nicholls,, P. A. Eagan,, M. Luther, and, M. L. Gulley. 2001. Analytic validation of a competitive polymerase chain reaction assay for measuring Epstein-Barr viral load. Diagn. Mol. Pathol. 10:255264.
90. Faraci, M.,, I. Caviglia,, G. Morreale,, E. Lanino,, D. Cuzzubbo,, S. Giardino,, M. E. Di,, C. Cirillo,, F. Scuderi,, S. Dallorso,, P. Terranova,, C. Moroni, and, E. Castagnola. 26 October 2009. Viral-load and B-lymphocyte monitoring of EBV reactivation after allogeneic hemopoietic SCT in children. Bone Marrow Transplant. doi:bmt2009302 [pii];10.1038/bmt.2009.302 [doi].
91. Fedele, C. G.,, A. Avellon,, M. Ciardi,, S. Delia, and, A. Tenorio. 2000. Quantitation of polyomavirus DNA by a competitive nested polymerase chain reaction. J. Virol. Methods 88:5161.
92. Fernandez, C.,, D. Boutolleau,, C. Manichanh,, N. Mangeney,, H. Agut, and, A. Gautheret-Dejean. 2002. Quantitation of HHV-7 genome by real-time polymerase chain reaction assay using MGB probe technology. J. Virol. Methods 106:1116.
93. Ferre, F. 1992. Quantitative or semi-quantitative PCR: reality versus myth. 2:19.
94. Ferreira-Gonzalez, A.,, S. Yanovich,, M. R. Langley,, L. A. Weymouth,, D. S. Wilkinson, and, C. T. Garrett. 2000. Enhanced analytical sensitivity of a quantitative PCR for CMV using a modified nucleic-acid extraction procedure. J. Clin. Lab. Anal. 14:3237.
95. Flexman, J.,, I. Kay,, R. Fonte,, R. Herrmann,, E. Gabbay, and, S. Palladino. 2001. Differences between the quantitative antigenemia assay and the Cobas Amplicor Monitor quantitative PCR assay for detecting CMV viraemia in bone marrow and solid organ transplant patients. J. Med. Virol. 64:275282.
96. Forman, M. S.,, and A. Valsamakis. 2008. Performance characteristics of a quantitative hepatitis C virus RNA assay using COBAS AmpliPrep total nucleic acid isolation and COBAS taqman hepatitis C virus analyte-specific reagent. J. Mol. Diagn. 10:147153.
97. [Reference deleted.]
98. Foy, C. A.,, and H. C. Parkes. 2001. Emerging homogenous DNA-based technologies in the clinical laboratory. Clin. Chem. 47:9901000.
99. Francesconi, A.,, M. Kasai,, R. Petraitiene,, V. Petraitis,, A. M. Kelaher,, R. Schaufele,, W. W. Hope,, Y. R. Shea,, J. Bacher, and, T. J. Walsh. 2006. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis. J. Clin. Microbiol. 44:24752480.
100. Fredricks, D. N.,, C. Smith, and, A. Meier. 2005. Comparison of six DNA extraction methods for recovery of fungal DNA as assessed by quantitative PCR. J. Clin. Microbiol. 43:51225128.
101. Funahashi, Y.,, S. Iwata,, Y. Ito,, S. Kojima,, T. Yoshikawa,, R. Hattori,, M. Gotoh,, Y. Nishiyama, and, H. Kimura. 2010. Multiplex real-time PCR assay for simultaneous quantification of BK polyomavirus, JC polyomavirus, and adenovirus DNA. J. Clin. Microbiol. 48:825830.
102. Funato, T.,, N. Satou,, D. Abukawa,, J. Satou,, Y. Abe,, K. K. Ishii,, K. Iinuma,, M. Kaku, and, T. Sasaski. 2001. Quantitative evaluation of cytomegalovirus DNA in infantile hepatitis. J. Viral Hepat. 8:217222.
103. Garcia de Viedma, D.,, R. Alonso,, P. Miralles,, J. Berenguer,, M. Rodriguez-Creixems, and, E. Bouza. 1999. Dual qualitative-quantitative nested PCR for detection of JC virus in cerebrospinal fluid: high potential for evaluation and monitoring of progressive multifocal leukoencephalopathy in AIDS patients receiving highly active antiretroviral therapy. J. Clin. Microbiol. 37:724728.
104. Garrigue, I.,, S. Boucher,, L. Couzi,, A. Caumont,, C. Dromer,, M. Neau-Cransac,, R. Tabrizi,, M. H. Schrive,, H. Fleury, and, M. E. Lafon. 2006. Whole blood realtime quantitative PCR for cytomegalovirus infection follow-up in transplant recipients. J. Clin. Virol. 36:7275.
105. Gautheret-Dejean, A.,, C. Manichanh,, F. Thien-Ah-Koon,, A. M. Fillet,, N. Mangeney,, M. Vidaud,, N. Dhedin,, J. P. Vernant, and, H. Agut. 2002. Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients. J. Virol. Methods 100:2735.
106. Germer, J. J.,, P. J. Heimgartner,, D. M. Ilstrup,, W. S. Harmsen,, G. D. Jenkins, and, R. Patel. 2002. Comparative evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR version 2.0 assays for quantification of hepatitis C virus RNA in serum. J. Clin. Microbiol. 40:495500.
107. Gervais, A.,, M. Martinot,, N. Boyer,, A. Auperin,, W. Le Breton,, C. Degott,, D. Valla, and, P. Marcellin. 2001. Quantitation of hepatic hepatitis C virus RNA in patients with chronic hepatitis C. Relationship with severity of disease, viral genotype and response to treatment. J. Hepatol. 35:399405.
108. Ghaffari, S. H.,, N. Obeidi,, M. Dehghan,, K. Alimoghaddam,, A. Gharehbaghian, and, A. Ghavamzadeh. 2008. Monitoring of cytomegalovirus reactivation in bone marrow transplant recipients by real-time PCR. Pathol. Oncol. Res. 14:399409.
109. Gibson, U. E.,, C. A. Heid, and, P. M. Williams. 1996. A novel method for real time quantitative RT-PCR. Genome Res. 6:9951001.
110. Gilbert, N.,, S. Corden,, S. Ijaz,, P. R. Grant,, R. S. Tedder, and, E. H. Boxall. 2002. Comparison of commercial assays for the quantification of HBV DNA load in health care workers: calibration differences. J. Virol. Methods 100:3747.
111. Glencross, D. K.,, G. Stevens,, L. E. Scott,, B. V. Mendelow, and, W. Stevens. 2002. The challenge of laboratory monitoring of HIV. S. Afr. Med. J. 92:248.
112. Gourlain, K.,, D. Salmon,, E. Gault,, C. Leport,, C. Katlama,, S. Matheron,, D. Costagliola,, M. C. Mazeron, and, A. M. Fillet. 2003. Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapy. J. Med. Virol. 69:401407.
113. Greenlee, D. J.,, H. Fan,, K. Lawless,, C. R. Harrison, and, M. L. Gulley. 2002. Quantitation of CMV by realtime PCR in transfusable RBC units. Transfusion 42:403408.
114. Greijer, A. E.,, H. M. Adriaanse,, C. A. Dekkers, and, J. M. Middeldorp. 2002. Multiplex real-time NASBA for monitoring expression dynamics of human cytomegalovirus encoded IE1 and pp67 RNA. J. Clin. Virol. 24:5766.
115. Gu, Z.,, S. W. Belzer,, C. S. Gibson,, M. J. Bankowski, and, R. T. Hayden. 2003. Multiplexed, real-time PCR for quantitative detection of human adenovirus. J. Clin. Microbiol. 41:46364641.
116. Gueudin, M.,, J. C. Plantier,, F. Damond,, P. Roques,, P. Mauclere, and, F. Simon. 2003. Plasma viral RNA assay in HIV-1 group O infection by real-time PCR. J. Virol. Methods 113:4349.
117. Gulley, M. L. 2001. Molecular diagnosis of Epstein-Barr virus-related diseases. J. Mol. Diagn. 3:110.
118. Gulley, M. L.,, and W. Tang. 2008. Laboratory assays for Epstein-Barr virus-related disease. J. Mol. Diagn. 10:279292.
119. Gunson, R. N.,, A. R. Maclean,, S. J. Shepherd, and, W. F. Carman. 2009. Simultaneous detection and quantitation of cytomegalovirus, Epstein-Barr virus, and adenovirus by use of real-time PCR and pooled standards. J. Clin. Microbiol. 47:765770.
120. Gustafson, I.,, A. Lindblom,, Z. Yun,, H. Omar,, L. Engstrom,, I. Lewensohn-Fuchs,, P. Ljungman, and, K. Broliden. 2008. Quantification of adenovirus DNA in unrelated donor hematopoietic stem cell transplant recipients. J. Clin. Virol. 43:7985.
121. Haberhausen, G.,, J. Pinsl,, C. C. Kuhn, and, C. Markert-Hahn. 1998. Comparative study of different standardization concepts in quantitative competitive reverse transcription-PCR assays. J. Clin. Microbiol. 36:628633.
122. Hakim, H.,, C. Gibson,, J. Pan,, K. Srivastava,, Z. Gu,, M. J. Bankowski, and, R. T. Hayden. 2007. Comparison of various blood compartments and reporting units for the detection and quantification of Epstein-Barr virus in peripheral blood. J. Clin. Microbiol. 45:21512155.
123. Halfon, P.,, M. Bourliere,, G. Penaranda,, H. Khiri, and, D. Ouzan. 2006. Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection. J. Clin. Microbiol. 44:25072511.
124. Hanfler, J.,, K. A. Kreuzer,, K. Laurisch,, S. Tomic,, H. Oettle, and, C. A. Schmidt. 2002. Quantitation of the spliced late gene of human cytomegalovirus and its kinetics during experimental infection. Med. Microbiol. Immunol. (Berlin) 190:161165.
125. Hayden, R.,, and D. H. Persing. 2001. Diagnostic molecular microbiology. Curr. Clin. Top. Infect. Dis. 21:323348.
126. Hayden, R. T.,, K. C. Carroll,, Y. W. Tang, and, D. M. Wolk. 2009. Diagnostic Microbiology of the Immunocompromised Host. ASM Press, Washington, DC.
127. Hayden, R. T.,, K. M. Hokanson,, S. B. Pounds,, M. J. Bankowski,, S. W. Belzer,, J. Carr,, D. Diorio,, M. S. Forman,, Y. Joshi,, D. Hillyard,, R. L. Hodinka,, M. N. Nikiforova,, C. A. Romain,, J. Stevenson,, A. Valsamakis, and, H. H. Balfour, Jr. 2008. Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virus. J. Clin. Microbiol. 46:157163.
128. Heid, C. A.,, J. Stevens,, K. J. Livak, and, P. M. Williams. 1996. Real time quantitative PCR. Genome Res. 6:986994.
129. Herman, J.,, M. Van Ranst,, R. Snoeck,, K. Beuselinck,, E. Lerut, and, R. Van Damme-Lombaerts. 2004. Polyomavirus infection in pediatric renal transplant recipients: evaluation using a quantitative real-time PCR technique. Pediatr. Transplant. 8:485492.
130. Hodinka, R. L. 1998. The clinical utility of viral quantitation using molecular methods. Clin. Diagn. Virol. 10:2547.
131. Hoffman, N. G.,, L. Cook,, E. E. Atienza,, A. P. Limaye, and, K. R. Jerome. 2008. Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assays. J. Clin. Microbiol. 46:26712680.
132. Holland, P. M.,, R. D. Abramson,, R. Watson, and, D. H. Gelfand. 1991. Detection of specific polymerase chain reaction product by utilizing the 5′–3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA 88:72767280.
133. Holmes, R. D.,, and R. J. Sokol. 2002. Epstein-Barr virus and post-transplant lymphoproliferative disease. Pediatr. Transplant. 6:456464.
134. Hoorfar, J.,, P. Wolffs, and, P. Radstrom. 2004. Diagnostic PCR: validation and sample preparation are two sides of the same coin. APMIS 112:808814.
135. Hu, K. Q. 2002. Occult hepatitis B virus infection and its clinical implications. J. Viral Hepat. 9:243257.
136. Humar, A.,, A. Asberg,, D. Kumar,, A. Hartmann,, G. Moussa,, A. Jardine,, H. Rollag,, H. Mouas,, C. G. Gahlemann, and, M. D. Pescovitz. 2009. An assessment of herpesvirus co-infections in patients with CMV disease: correlation with clinical and virologic outcomes. Am. J. Transplant. 9:374381.
137. Izraeli, S.,, C. Pfleiderer, and, T. Lion. 1991. Detection of gene expression by PCR amplification of RNA derived from frozen heparinized whole blood. Nucleic Acids Res. 19:6051.
138. Jebbink, J.,, X. Bai,, B. B. Rogers,, D. B. Dawson,, R. H. Scheuermann, and, R. Domiati-Saad. 2003. Development of real-time PCR assays for the quantitative detection of Epstein-Barr virus and cytomegalovirus, comparison of TaqMan probes, and molecular beacons. J. Mol. Diagn. 5:1520.
139. Johanson, J.,, K. Abravaya,, W. Caminiti,, D. Erickson,, R. Flanders,, G. Leckie,, E. Marshall,, C. Mullen,, Y. Ohhashi,, R. Perry,, J. Ricci,, J. Salituro,, A. Smith,, N. Tang,, M. Vi, and, J. Robinson. 2001. A new ultrasensitive assay for quantitation of HIV-1 RNA in plasma. J. Virol. Methods 95:8192.
140. John, G. C.,, H. Sheppard,, D. Mbori-Ngacha,, R. Nduati,, D. Maron,, M. Reiner, and, J. Kreiss. 2001. Comparison of techniques for HIV-1 RNA detection and quantitation in cervicovaginal secretions. J. Acquir. Immune Defic. Syndr. 26:170175.
141. Jorgensen, P. A.,, and P. D. Neuwald. 2001. Standardized hepatitis C virus RNA panels for nucleic acid testing assays. J. Clin. Virol. 20:3540.
142. Jun, E. J.,, J. Y. Han,, H. Choi,, U. I. Chang,, T. K. Lee,, Y. H. Kim,, J. I. Kim,, S. H. Park,, J. K. Kim,, K. W. Chung, and, H. S. Sun. 2002. The clinical significance of quantitation of HBV DNA in serum-comparison of the branched-DNA assay with the second-generation digene hybrid capture assay and long-term observation. Taehan Kan Hakhoe Chi 8:157166. (In Korean.)
143. Jungkind, D.,, and H. H. Kessler. 2002. Molecular methods for diagnosis of infectious disease, p. 306-323. In A. L. Truant (ed.), Manual of Commercial Methods in Clinical Microbiology. ASM Press, Washington, DC.
144. Kaneko, K.,, R. Okamoto,, R. Nakano,, S. Kawakami, and, M. Inoue. 2005. Gene mutations responsible for overexpression of AmpC beta-lactamase in some clinical isolates of Enterobacter cloacae. J. Clin. Microbiol. 43:29552958.
145. Kato, N.,, O. Yokosuka,, K. Hosoda,, Y. Ito,, M. Ohto, and, M. Omata. 1993. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology 18:1620.
146. Kawai, S.,, O. Yokosuka,, F. Imazeki,, H. Saisho, and, C. Mizuno. 2002. Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level. J. Med. Virol. 68:343351.
147. Kawazu, M.,, Y. Kanda,, S. Goyama,, M. Takeshita,, Y. Nannya,, M. Niino,, Y. Komeno,, T. Nakamoto,, M. Kurokawa,, S. Tsujino,, S. Ogawa,, K. Aoki,, S. Chiba,, T. Motokura,, N. Ohishi, and, H. Hirai. 2003. Rapid diagnosis of invasive pulmonary aspergillosis by quantitative polymerase chain reaction using bronchial lavage fluid. Am. J. Hematol. 72:2730.
148. Kearns, A. M.,, A. J. Turner,, G. J. Eltringham, and, R. Freeman. 2002. Rapid detection and quantification of CMV DNA in urine using LightCycler-based real-time PCR. J. Clin. Virol. 24:131134.
149. Kellogg, J. A.,, P. V. Atria,, J. C. Sanders, and, M. E. Eyster. 2001. Intra- and interlaboratory variabilities of results obtained with the Quantiplex human immunodeficiency virus type 1 RNA bDNA assay, version 3.0. Clin. Diagn. Lab. Immunol. 8:560563.
150. Khodakov, D. A.,, N. V. Zakharova,, D. A. Gryadunov,, F. P. Filatov,, A. S. Zasedatelev, and, V. M. Mikhailovich. 2008. An oligonucleotide microarray for multiplex real-time PCR identification of HIV-1, HBV, and HCV. BioTechniques 44:241246, 248.
151. Khot, P. D.,, D. L. Ko,, R. C. Hackman, and, D. N. Fredricks. 2008. Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. BMC Infect. Dis. 8:73.
152. Kimura, H.,, Y. Ito,, M. Futamura,, Y. Ando,, Y. Yabuta,, Y. Hoshino,, Y. Nishiyama, and, T. Morishima. 2002. Quantitation of viral load in neonatal herpes simplex virus infection and comparison between type 1 and type 2. J. Med. Virol. 67:349353.
153. Kleiber, J.,, T. Walter,, G. Haberhausen,, S. Tsang,, R. Babiel, and, M. Rosenstraus. 2000. Performance characteristics of a quantitative, homogeneous TaqMan RTPCR test for HCV RNA. J. Mol. Diagn. 2:158166.
154. Kletzmayr, J.,, B. Watschinger,, C. Muller,, D. Demetriou,, E. Puchhammer-Stockl,, P. Ferenci, and, J. Kovarik. 2000. Twelve months of lamivudine treatment for chronic hepatitis B virus infection in renal transplant recipients. Transplantation 70:14041407.
155. Komurian-Pradel, F.,, G. Paranhos-Baccala,, M. Sodoyer,, P. Chevallier,, B. Mandrand,, V. Lotteau, and, P. Andre. 2001. Quantitation of HCV RNA using realtime PCR and fluorimetry. J. Virol. Methods 95:111119.
156. Kochanowski, B.,, and U. Reischl (ed.). 1999. Quantitative PCR Protocols. SpringerProtocols, Methods in Molecular Medicine, vol. 26. Humana Press, Totowa, NJ.
157. Kostrikis, L. G.,, G. Touloumi,, R. Karanicolas,, N. Pantazis,, C. Anastassopoulou,, A. Karafoulidou,, J. J. Goedert, and, A. Hatzakis. 2002. Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load. J. Virol. 76:1009910108.
158. Krouwer, J. S. 2002. Assay Development and Evaluation: A Manufacturer’s Perspective. American Association for Clinical Chemistry, Washington, DC.
159. Kubista, M.,, J. M. Andrade,, M. Bengtsson,, A. Forootan,, J. Jonak,, K. Lind,, R. Sindelka,, R. Sjoback,, B. Sjogreen,, L. Strombom,, A. Stahlberg, and, N. Zoric. 2006. The real-time polymerase chain reaction. Mol. Aspects Med. 27:95125.
160. Kukuczka, S.,, and L. E. Grosso. 2002. Effective management of hepatitis C molecular testing improves test use without compromising patient management. Arch. Pathol. Lab. Med. 126:100102.
161. Lau, G. K.,, Y. H. Leung,, D. Y. Fong,, W. Y. Au,, Y. L. Kwong,, A. Lie,, J. L. Hou,, Y. M. Wen,, A. Nanj, and, R. Liang. 2002. High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation. Blood 99:23242330.
162. Leb, V.,, M. Stocher,, E. Valentine-Thon,, G. Holzl,, H. Kessler,, H. Stekel, and, J. Berg. 2004. Fully automated, internally controlled quantification of hepatitis B virus DNA by real-time PCR by use of the MagNA Pure LC and LightCycler instruments. J. Clin. Microbiol. 42:585590.
163. Lee, L. G.,, K. J. Livak,, B. Mullah,, R. J. Graham,, R. S. Vinayak, and, T. M. Woudenberg. 1999. Seven-color, homogeneous detection of six PCR products. BioTechniques 27:342349.
164. Lee, Y. S.,, S. K. Yoon,, E. S. Chung,, S. H. Bae,, J. Y. Choi,, J. Y. Han,, K. W. Chung,, H. S. Sun,, B. S. Kim, and, B. K. Kim. 2001. The relationship of histologic activity to serum ALT, HCV genotype and HCV RNA titers in chronic hepatitis C. J. Korean Med. Sci. 16:585591.
165. Le Guillou-Guillemette, H.,, and F. Lunel-Fabiani. 2009. Detection and quantification of serum or plasma HCV RNA: mini review of commercially available assays. Methods Mol. Biol. 510:314.
166. Lerma, J. G.,, V. Soriano,, A. Mas,, M. E. Quinones-Mateu,, E. J. Arts, and, W. Heneine. 2000. Quantitation of human immunodeficiency virus type 1 group O load in plasma by measuring reverse transcriptase activity. J. Clin. Microbiol. 38:402405.
167. Liang, S. L.,, M. T. Lin,, M. J. Hafez,, C. D. Gocke,, K. M. Murphy,, L. J. Sokoll, and, J. R. Eshleman. 2008. Application of traditional clinical pathology quality control techniques to molecular pathology. J. Mol. Diagn. 10:142146.
168. Lilleri, D.,, F. Baldanti,, M. Gatti,, F. Rovida,, L. Dossena,, G. S. De,, M. Torsellini, and, G. Gerna. 2004. Clinicallybased determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients. J. Med. Virol. 73:412418.
169. Limaye, A. P.,, K. R. Jerome,, C. S. Kuhr,, J. Ferrenberg,, M. L. Huang,, C. L. Davis,, L. Corey, and, C. L. Marsh. 2001. Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients. J. Infect. Dis. 183:16691672.
170. Lin, M. H.,, T. C. Chen,, T. T. Kuo,, C. C. Tseng, and, C. P. Tseng. 2000. Real-time PCR for quantitative detection of Toxoplasma gondii. J. Clin. Microbiol. 38:41214125.
171. Lisker-Melman, M.,, and G. S. Sayuk. 2007. Defining optimal therapeutic outcomes in chronic hepatitis. Arch. Med. Res. 38:652660.
172. Livak, K. J.,, S. J. Flood,, J. Marmaro,, W. Giusti, and, K. Deetz. 1995. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl. 4:357362.
173. Lo, Y. M.,, A. T. Chan,, L. Y. Chan,, S. F. Leung,, C. W. Lam,, D. P. Huang, and, P. J. Johnson. 2000. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. Cancer Res. 60:68786881.
174. Loeb, K. R.,, K. R. Jerome,, J. Goddard,, M. Huang,, A. Cent, and, L. Corey. 2000. High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system. Hepatology 32:626629.
175. Loeffler, J.,, N. Henke,, H. Hebart,, D. Schmidt,, L. Hagmeyer,, U. Schumacher, and, H. Einsele. 2000. Quantification of fungal DNA by using fluorescence resonance energy transfer and the light cycler system. J. Clin. Microbiol. 38:586590.
176. Loeffler, J.,, K. Kloepfer,, H. Hebart,, L. Najvar,, J. R. Graybill,, W. R. Kirkpatrick,, T. F. Patterson,, K. Dietz,, R. Bialek, and, H. Einsele. 2002. Polymerase chain reaction detection of aspergillus DNA in experimental models of invasive aspergillosis. J. Infect. Dis. 185:12031206.
177. Loginov, R.,, S. Aalto,, H. Piiparinen,, L. Halme,, J. Arola,, K. Hedman,, K. Hockerstedt, and, I. Lautenschlager. 2006. Monitoring of EBV-DNAemia by quantitative real-time PCR after adult liver transplantation. J. Clin. Virol. 37:104108.
178. Lopez, V. A.,, E. J. Bourne,, M. W. Lutz, and, L. D. Condreay. 2002. Assessment of the COBAS Amplicor HBV Monitor Test for quantitation of serum hepatitis B virus DNA levels. J. Clin. Microbiol. 40:19721976.
179. Lyamuya, E.,, E. Olausson-Hansson,, J. Albert,, F. Mhalu, and, G. Biberfeld. 2000. Evaluation of a prototype Amplicor PCR assay for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults infected with HIV-1 subtypes A, C and D. J. Clin. Virol. 17:5763.
180. Maaroufi, Y.,, J. M. de Bruyne,, V. Duchateau,, R. Scheen, and, F. Crokaert. 2006. Development of a multiple internal control for clinical diagnostic real-time amplification assays. FEMS Immunol. Med. Microbiol. 48:183191.
181. Machida, U.,, M. Kami,, T. Fukui,, Y. Kazuyama,, M. Kinoshita,, Y. Tanaka,, Y. Kanda,, S. Ogawa,, H. Honda,, S. Chiba,, K. Mitani,, Y. Muto,, K. Osumi,, S. Kimura, and, H. Hirai. 2000. Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation. J. Clin. Microbiol. 38:25362542.
182. Maine, G. T.,, T. Lazzarotto, and, M. P. Landini. 2001. New developments in the diagnosis of maternal and congenital CMV infection. Expert Rev. Mol. Diagn. 1:1929.
183. Mansfield, E.,, T. J. O’Leary, and, S. I. Gutman. 2005. Food and Drug Administration regulation of in vitro diagnostic devices. J. Mol. Diagn. 7:27.
184. Marconi, A.,, M. Balestrieri,, G. Comastri,, F. R. Pulvirenti,, W. Gennari,, S. Tagliazucchi,, M. Pecorari,, V. Borghi,, D. Marri, and, M. Zazzi. 2009. Evaluation of the Abbott Real-Time HIV-1 quantitative assay with dried blood spot specimens. Clin. Microbiol. Infect. 15:9397.
185. Martell, M.,, J. Gomez,, J. I. Esteban,, S. Sauleda,, J. Quer,, B. Cabot,, R. Esteban, and, J. Guardia. 1999. High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA. J. Clin. Microbiol. 37:327332.
186. Martin, G. P.,, and E. Timmers. 1997. PCR and its modifications for the detection of infectious diseases, p. 79-99. In H. Lee,, S. Morse, and, O. Olsvik (ed.), Nucleic Acid Amplification Technologies: Application to Disease Diagnosis. Eaton Publishing, Natick, MA.
187. Martin, P.,, and D. M. Jensen. 2008. Ribavirin in the treatment of chronic hepatitis C. J. Gastroenterol. Hepatol. 23:844855.
188. Martin-Davila, P.,, J. Fortun,, C. Gutierrez,, P. Marti-Belda,, A. Candelas,, A. Honrubia,, R. Barcena,, A. Martinez,, A. Puente,, E. de Vicente, and, S. Moreno. 2005. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value. J. Clin. Virol. 33:138144.
189. Martinelli, A.,, D. Brown,, A. Morris,, A. Dhillon,, P. Dayley, and, G. Dusheiko. 2000. Quantitation of HCV RNA in liver of patients with chronic hepatitis C. Arq. Gastroenterol. 37:203207.
190. McCallum, N.,, B. Berger-Bachi, and, M. M. Senn. 2010. Regulation of antibiotic resistance in Staphylococcus aureus. Int. J. Med. Microbiol. 300:118129.
191. McEwan, N. R.,, J. Bakht,, E. Cecchini,, A. Coultart,, C. Geri,, F. M. McDonald,, M. S. McDonald,, N. Norulaini,, A. Rahman, and, G. Williamson. 1998. Examination of the pipetting variation between individuals performing random amplified polymorphic DNA (RAPD) alaysis. J. Microbiol. Methods 32:213215.
192. McHutchison, J. G.,, T. Poynard,, R. Esteban-Mur,, G. L. Davis,, Z. D. Goodman,, J. Harvey,, M. H. Ling,, J. J. Garaud,, J. K. Albrecht,, K. Patel,, J. L. Dienstag, and, T. Morgan. 2002. Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin. Hepatology 35:688693.
193. McNees, A. L.,, Z. S. White,, P. Zanwar,, R. A. Vilchez, and, J. S. Butel. 2005. Specific and quantitative detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR. J. Clin. Virol. 34:5262.
194. Mendez, J. C.,, D. H. Dockrell,, M. J. Espy,, T. F. Smith,, J. A. Wilson,, W. S. Harmsen,, D. Ilstrup, and, C. V. Paya. 2001. Human beta-herpesvirus interactions in solid organ transplant recipients. J. Infect. Dis. 183:179184.
195. Mengelle, C.,, F. Legrand-Abravanel,, J. M. Mansuy,, C. Barthe,, S. Da, I, and, J. Izopet. 2008. Comparison of two highly automated DNA extraction systems for quantifying Epstein-Barr virus in whole blood. J. Clin. Virol. 43:272276.
196. Merlino, C.,, M. Bergallo,, G. Gregori,, F. Sinesi,, C. Bollero, and, R. Cavallo. 2002. HCMV pp67-mRNA detection by nucleic acid sequence-based amplification in renal transplant patients. New Microbiol. 25:18.
197. Merlino, C.,, M. Bergallo,, G. Gribaudo,, G. Gregori,, S. G. Paolo,, F. Giacchino,, A. N. Ponzi, and, R. Cavallo. 2003. Polyomavirus BK DNA quantification assay to evaluate viral load in renal transplant recipients. J. Clin. Virol. 28:265274.
198. Miller, S.,, H. Seet,, Y. Khan,, C. Wright, and, R. Nadarajah. 2010. Comparison of QIAGEN automated nucleic acid extraction methods for CMV quantitative PCR testing. Am. J. Clin. Pathol. 133:558563.
199. Miura-Ochiai, R.,, Y. Shimada,, T. Konno,, S. Yamazaki,, K. Aoki,, S. Ohno,, E. Suzuki, and, H. Ishiko. 2007. Quantitative detection and rapid identification of human adenoviruses. J. Clin. Microbiol. 45:958967.
200. Mulligan, E. K.,, J. J. Germer,, M. Q. Arens,, K. L. D’Amore,, B. A. Di,, N. A. Ledeboer,, M. J. Moser,, A. C. Newman,, A. K. O’Guin,, P. D. Olivo,, D. S. Podzorski,, K. A. Vaughan,, J. D. Yao,, S. A. Elagin, and, S. C. Johnson. 2009. Detection and quantification of hepatitis C virus (HCV) by MultiCode-RTx real-time PCR targeting the HCV 3′ untranslated region. J. Clin. Microbiol. 47:26352638.
201. Murphy, J.,, and S. A. Bustin. 2009. Reliability of realtime reverse-transcription PCR in clinical diagnostics: gold standard or substandard? Expert Rev. Mol. Diagn. 9:187197.
202. Musher, B.,, D. Fredricks,, W. Leisenring,, S. A. Balajee,, C. Smith, and, K. A. Marr. 2004. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J. Clin. Microbiol. 42:55175522.
203. Mutimer, D.,, D. Pillay,, P. Shields,, P. Cane,, D. Ratcliffe,, B. Martin,, S. Buchan,, L. Boxall,, K. O’Donnell,, J. Shaw,, S. Hubscher, and, E. Elias. 2000. Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient. Gut 46:107113.